Mawer Investment Management Ltd. lowered its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 45.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 427,512 shares of the company’s stock after selling 357,017 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Procter & Gamble were worth $62,109,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of Procter & Gamble during the second quarter worth $27,862,105,000. Bank of America Corp DE bought a new stake in Procter & Gamble in the second quarter valued at about $3,850,628,000. Bank of New York Mellon Corp acquired a new position in Procter & Gamble in the second quarter valued at about $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Procter & Gamble in the second quarter valued at about $1,480,650,000. Finally, Corient Private Wealth LP bought a new position in Procter & Gamble during the second quarter worth about $335,908,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity
In other news, CFO Andre Schulten sold 33,624 shares of the business’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $165.00, for a total value of $5,547,960.00. Following the sale, the chief financial officer directly owned 65,618 shares in the company, valued at $10,826,970. The trade was a 33.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Shailesh Jejurikar sold 35,000 shares of the business’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $163.09, for a total value of $5,708,150.00. Following the completion of the sale, the chief executive officer owned 55,391 shares in the company, valued at approximately $9,033,718.19. This trade represents a 38.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 200,006 shares of company stock worth $32,715,058. 0.23% of the stock is currently owned by insiders.
Procter & Gamble Stock Up 1.1%
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.11. The business had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The firm’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period last year, the business posted $1.99 earnings per share. Analysts anticipate that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is 65.51%.
Key Procter & Gamble News
Investors following PG have been watching these news items:
- Positive Sentiment: P&G’s latest quarter beat expectations: earnings were $2.00 per share versus $1.89 expected, and revenue was $23.28 billion versus $22.80 billion expected, up 4% year over year. The results have helped lift shares toward a 52-week high. Article: Procter & Gamble Has Raised Its Dividend for 70 Straight Years
- Neutral Sentiment: Recent valuation coverage asks whether P&G’s current market value is justified by its expected cash flows and how its valuation compares with rivals. This may make valuation more salient after the stock’s recent gains, but the available article summaries do not provide a specific fair-value estimate. Article: Is Procter & Gamble Stock Worth More Than Its Rivals?
- Negative Sentiment: CEO El Hak Hesham Abd sold 2,250 shares for about $379,000, reducing his direct ownership by 20.06% to 8,968 shares. The sale may draw attention, although a single transaction does not establish a change in the company’s outlook. SEC Form 4 filing
Analyst Ratings Changes
Several equities analysts have recently issued reports on the company. TD Cowen boosted their target price on Procter & Gamble from $150.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, October 23rd. Freedom Broker raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 price target for the company in a research note on Friday, October 23rd. UBS Group set a $166.00 price target on shares of Procter & Gamble in a research report on Friday, October 23rd. DZ Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Finally, Barclays boosted their price objective on shares of Procter & Gamble from $152.00 to $165.00 and gave the company an “equal weight” rating in a report on Monday, October 26th. Fifteen analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $170.57.
View Our Latest Analysis on PG
About Procter & Gamble
The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.
See Also
- Five stocks we like better than Procter & Gamble
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
